Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

MRIGlobal to Deploy Mobile Labs to Sierra Leone

by Global Biodefense Staff
December 16, 2014
USAMRIID Ebola Laboratory

A technician sets up an assay for Ebola within a containment laboratory. Samples are handled in negative-pressure biological safety cabinets to provide an additional layer of protection. Credit: U.S. Army photo by Dr. Randal J. Schoepp

MRIGlobal has been awarded a contract to configure, equip, deploy and staff two quick response mobile laboratory systems (MLS) to support the ongoing Ebola outbreak in West Africa.

The contract was awarded by the Defense Threat Reduction Agency (DTRA) on behalf of the Cooperative Threat Reduction Program (CTR), and is valued at $4,000,000. If follow on tasks/options are exercised, the total value of the contract could reach approximately $11,000,000.

This contract will completely outfit, prepare for shipping and operations, operate and sustain two mobile diagnostic laboratories for deployment to Sierra Leone.

MRIGlobal will help meet an urgent need for laboratory and technical capacity to perform diagnostics on potential Ebola samples in the country. The lack of an adequate diagnostics capability directly results in the increased exposures and spread of the deadly virus.

The mobile laboratory units deployed by MRIGlobal will be appropriately outfitted to perform high volume lab testing with the appropriate biosafety controls in austere environments. Existing Department of Defense modular laboratory units were previously designed and configured MRI Global, uniquely positioning the organization to meet the call for a rapid custom re-configuration of these modular units for the mission in Sierra Leone.

“MRI Global is able to retrofit the units within a very aggressive timeline because of their familiarity with the units,” states the DTRA announcement. “In a matter of weeks, this contractor team will be required to deploy with the lab units and ready to operate these labs immediately upon arrivaI. There is Iittle to no “ramp up” time.”

The CDC has estimated that each infected patient infects on average nearly two additional people. The risk of exposure may be mitigated with the increased laboratory capacity, and the faster that these units can be deployed the greater the chance of slowing and containing the disease epidemic in Sierra Leone.

Tags: BiosafetyCooperative Threat ReductionDefense Threat Reduction AgencyEbolaEmerging Threats

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy